vs
ImmunityBio, Inc.（IBRX）与RCI HOSPITALITY HOLDINGS, INC.（RICK）财务数据对比。点击上方公司名可切换其他公司
RCI HOSPITALITY HOLDINGS, INC.的季度营收约是ImmunityBio, Inc.的1.9倍（$70.9M vs $38.3M），RCI HOSPITALITY HOLDINGS, INC.净利率更高（-7.8% vs -161.8%，领先154.0%），ImmunityBio, Inc.同比增速更快（407.0% vs -3.1%），RCI HOSPITALITY HOLDINGS, INC.自由现金流更多（$11.5M vs $-71.3M）
ImmunityBio, Inc.是一家处于临床阶段的生物技术企业，专注开发针对多种癌症及传染性疾病的下一代免疫疗法与候选疫苗，核心研发方向涵盖细胞疗法、抗体药物及靶向疫苗平台，主要运营市场位于美国。
RCI Hospitality控股通过子公司经营脱衣舞俱乐部、夜总会、运动酒吧与餐厅，同时还运营一家为成人俱乐部行业提供服务的传媒会展企业。公司于1995年完成首次公开募股上市，目前在纳斯达克全球市场挂牌交易。
IBRX vs RICK — 直观对比
营收规模更大
RICK
是对方的1.9倍
$38.3M
营收增速更快
IBRX
高出410.1%
-3.1%
净利率更高
RICK
高出154.0%
-161.8%
自由现金流更多
RICK
多$82.8M
$-71.3M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $38.3M | $70.9M |
| 净利润 | $-61.9M | $-5.5M |
| 毛利率 | 99.0% | — |
| 营业利润率 | -169.0% | -0.7% |
| 净利率 | -161.8% | -7.8% |
| 营收同比 | 407.0% | -3.1% |
| 净利润同比 | -4.7% | -2354.9% |
| 每股收益（稀释后） | $-0.06 | $-0.60 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IBRXRICK
| Q4 25 | $38.3M | — | ||
| Q3 25 | $32.1M | $70.9M | ||
| Q2 25 | $26.4M | $71.1M | ||
| Q1 25 | $16.5M | $65.9M | ||
| Q4 24 | $7.6M | $71.5M | ||
| Q3 24 | $6.1M | $73.2M | ||
| Q2 24 | — | $76.2M | ||
| Q1 24 | — | $72.3M |
净利润IBRXRICK
| Q4 25 | $-61.9M | — | ||
| Q3 25 | $-67.3M | $-5.5M | ||
| Q2 25 | $-92.6M | $4.1M | ||
| Q1 25 | $-129.6M | $3.2M | ||
| Q4 24 | $-59.2M | $9.0M | ||
| Q3 24 | $-85.7M | $244.0K | ||
| Q2 24 | — | $-5.2M | ||
| Q1 24 | — | $774.0K |
毛利率IBRXRICK
| Q4 25 | 99.0% | — | ||
| Q3 25 | 99.4% | — | ||
| Q2 25 | 99.5% | — | ||
| Q1 25 | 99.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率IBRXRICK
| Q4 25 | -169.0% | — | ||
| Q3 25 | -173.5% | -0.7% | ||
| Q2 25 | -269.8% | 12.2% | ||
| Q1 25 | -390.1% | 12.4% | ||
| Q4 24 | -919.0% | 19.5% | ||
| Q3 24 | -1314.3% | 4.8% | ||
| Q2 24 | — | -3.3% | ||
| Q1 24 | — | 6.4% |
净利率IBRXRICK
| Q4 25 | -161.8% | — | ||
| Q3 25 | -209.8% | -7.8% | ||
| Q2 25 | -350.3% | 5.7% | ||
| Q1 25 | -784.9% | 4.9% | ||
| Q4 24 | -783.4% | 12.6% | ||
| Q3 24 | -1404.0% | 0.3% | ||
| Q2 24 | — | -6.9% | ||
| Q1 24 | — | 1.1% |
每股收益（稀释后）IBRXRICK
| Q4 25 | $-0.06 | — | ||
| Q3 25 | $-0.07 | $-0.60 | ||
| Q2 25 | $-0.10 | $0.46 | ||
| Q1 25 | $-0.15 | $0.36 | ||
| Q4 24 | $-0.08 | $1.01 | ||
| Q3 24 | $-0.14 | $0.04 | ||
| Q2 24 | — | $-0.56 | ||
| Q1 24 | — | $0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $242.8M | $33.7M |
| 总债务越低越好 | — | $238.2M |
| 股东权益账面价值 | $-500.5M | $261.1M |
| 总资产 | $501.9M | $596.9M |
| 负债/权益比越低杠杆越低 | — | 0.91× |
8季度趋势，按日历期对齐
现金及短期投资IBRXRICK
| Q4 25 | $242.8M | — | ||
| Q3 25 | $257.8M | $33.7M | ||
| Q2 25 | $153.7M | $29.3M | ||
| Q1 25 | $61.6M | $32.7M | ||
| Q4 24 | $149.8M | $34.7M | ||
| Q3 24 | $130.4M | $32.4M | ||
| Q2 24 | — | $34.9M | ||
| Q1 24 | — | $20.0M |
总债务IBRXRICK
| Q4 25 | — | — | ||
| Q3 25 | — | $238.2M | ||
| Q2 25 | — | $243.8M | ||
| Q1 25 | — | $244.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $241.1M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益IBRXRICK
| Q4 25 | $-500.5M | — | ||
| Q3 25 | $-524.3M | $261.1M | ||
| Q2 25 | $-570.7M | $269.5M | ||
| Q1 25 | $-591.4M | $268.8M | ||
| Q4 24 | $-489.1M | $269.0M | ||
| Q3 24 | $-745.1M | $263.4M | ||
| Q2 24 | — | $271.2M | ||
| Q1 24 | — | $285.8M |
总资产IBRXRICK
| Q4 25 | $501.9M | — | ||
| Q3 25 | $519.0M | $596.9M | ||
| Q2 25 | $402.1M | $597.4M | ||
| Q1 25 | $303.8M | $589.8M | ||
| Q4 24 | $382.9M | $586.2M | ||
| Q3 24 | $364.6M | $584.4M | ||
| Q2 24 | — | $601.0M | ||
| Q1 24 | — | $609.9M |
负债/权益比IBRXRICK
| Q4 25 | — | — | ||
| Q3 25 | — | 0.91× | ||
| Q2 25 | — | 0.90× | ||
| Q1 25 | — | 0.91× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.92× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-70.4M | $13.7M |
| 自由现金流经营现金流 - 资本支出 | $-71.3M | $11.5M |
| 自由现金流率自由现金流/营收 | -186.2% | 16.2% |
| 资本支出强度资本支出/营收 | 2.4% | 3.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-308.8M | $34.9M |
8季度趋势，按日历期对齐
经营现金流IBRXRICK
| Q4 25 | $-70.4M | — | ||
| Q3 25 | $-68.9M | $13.7M | ||
| Q2 25 | $-79.7M | $13.8M | ||
| Q1 25 | $-85.9M | $8.5M | ||
| Q4 24 | $-85.1M | $13.3M | ||
| Q3 24 | $-98.8M | $15.7M | ||
| Q2 24 | — | $15.8M | ||
| Q1 24 | — | $10.8M |
自由现金流IBRXRICK
| Q4 25 | $-71.3M | — | ||
| Q3 25 | $-69.6M | $11.5M | ||
| Q2 25 | $-80.8M | $10.1M | ||
| Q1 25 | $-87.0M | $5.7M | ||
| Q4 24 | $-87.3M | $7.6M | ||
| Q3 24 | $-101.6M | $10.3M | ||
| Q2 24 | — | $9.3M | ||
| Q1 24 | — | $3.2M |
自由现金流率IBRXRICK
| Q4 25 | -186.2% | — | ||
| Q3 25 | -217.2% | 16.2% | ||
| Q2 25 | -305.9% | 14.2% | ||
| Q1 25 | -526.9% | 8.6% | ||
| Q4 24 | -1155.4% | 10.6% | ||
| Q3 24 | -1663.2% | 14.0% | ||
| Q2 24 | — | 12.3% | ||
| Q1 24 | — | 4.4% |
资本支出强度IBRXRICK
| Q4 25 | 2.4% | — | ||
| Q3 25 | 2.3% | 3.2% | ||
| Q2 25 | 4.1% | 5.2% | ||
| Q1 25 | 6.8% | 4.3% | ||
| Q4 24 | 28.0% | 8.0% | ||
| Q3 24 | 45.7% | 7.3% | ||
| Q2 24 | — | 8.4% | ||
| Q1 24 | — | 10.6% |
现金转化率IBRXRICK
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 3.40× | ||
| Q1 25 | — | 2.65× | ||
| Q4 24 | — | 1.48× | ||
| Q3 24 | — | 64.14× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 14.00× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IBRX
暂无分部数据
RICK
| Transferred At Point In Time | $60.8M | 86% |
| Food And Merchandise | $10.4M | 15% |
